The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...

Medicare negotiations of prescription drug prices could have cut seniors' out-of-pocket costs by nearly a quarter had the program been in effect in 2021, according to an analysis Mathematica provided ...

The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining ...

Controls on drug prices will stifle our ability to innovate while also damaging the economy, Alexandria economist Justin Vélez-Hagan, Ph.D., writes in a guest column.

Only one company has responded to an FTC demand for several drugmakers to delist dozens of patents that were improperly or ...

The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...

We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...

4 Large Drugmakers Trying to Survive the Industry Challenges Novo Nordisk : It has one of the broadest diabetes portfolios in the industry, with an extensive portfolio of insulin drugs and ...

Joe Biden has made it less likely that we’ll find a cure for Alzheimer’s any time soon. That’s a consequence of his ordering Medicare to “negotiate” with pharmaceutical firms over the ...

Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and ...

The consumer price index is a weighted average collection of the prices of common goods and services. Changes in the CPI over time are used to estimate the rate of inflation. The consumer price ...

The third-quarter earnings season has just concluded for the drug and biotech sector. The performance of the large drugmakers was rather lukewarm, with most posting mixed results. Higher tax rates ...